- Professor, Global Health
- Professor, Medicine - Allergy and Infectious Dis.
- Adjunct Professor, Epidemiology
University of Washington
Select from the following:
Connie Celum, MD, MPH, is Professor of Global Health, Medicine, and Epidemiology and Director of the International Clinical Research Center at the University of Washington. She is an infectious disease physician, epidemiologist, and clinical researcher. Her research interests focus on HIV prevention strategies, including HIV pre-exposure prophylaxis and prevention and treatment of sexually-transmitted infections. She has led multi-center HIV prevention efficacy trials, including genital herpes suppression for prevention of HIV acquisition as well as HIV transmission. She co-led the Partners PrEP Study, which demonstrated high efficacy of tenofovir and emtricitabine-tenofovir prophylaxis, which contributed to FDA approval of PrEP for HIV prevention. Currently Dr. Celum’s research is focusing on implementation science research about PrEP implementation and STI interventions for young African women and MSM in the US. She is the co-Principal Investigator for the DoxyPEP study to evaluate doxycycline post-exposure prophylaxis for MSM and TGW living with HIV and on PrEP.
- MD (University of California (San Francisco))
- MPH (University of Washington)
- BA (Stanford University)
- HIV Transmission
- STDs (other than HIV)
- CFAR: Behavioral Science Core
- DO ART: Delivery Optimization of ART
- DoxyPEP: Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men and transgender women
- HIV Prevention Trials Network
- HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda
- Microbicide Trials Network
- POWER: Scaleable, Effective Delivery of Microbicides and PrEP for Young Women in Kenya and South Africa
- PrEP for young South African women: Evaluating uptake by risk screening or a decision support tool and scaled adherence support using a SMART design
Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Stevens W, Campbell MS, Thomas KK, Coombs RW, Morrow R, Whittington WL, McElrath MJ, Barnes L, Ridzon R, Corey L; Partners in Prevention HSV/HIV Transmission Study Team. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362:427-39. PMCID: 2838503
Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C; Partners in Prevention HSV/HIV Transmission Study Team. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092-8. PMCID: 2922041.
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C; Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399-410. PMCID: 3770474.
Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, Asiimwe S, Haberer JE, Morton J, Ngure K, Bulya N, Odoyo J, Tindimwemba E, Hendrix C, Marzinke M, Ware N, Wyatt M, Morrison S, Haugen H, Mujugira A, Donnell D, Celum C; Partners Demonstration Project Team. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1–serodiscordant couples: A prospective implementation study in Kenya and Uganda. PLoS Med. 2016;13:e1002. doi: 10.1371/journal.pmed.1002099. PMCID: 4995047.
Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi E, McConnell M, Barnabas R, Bekker L-G. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: From efficacy trials to delivery. J Intl AIDS Soc. 2019;22:e25298. doi: 10.1002/jia2.25298.